According to Pacira Biosciences 's latest financial reports and stock price the company's current number of shares outstanding is 46,416,000. At the end of 2023 the company had 46,416,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 46.41 M | 1.16% |
2022 | 45.88 M | 2.89% |
2021 | 44.59 M | 2.51% |
2020 | 43.5 M | 4.11% |
2019 | 41.78 M | 1.55% |
2018 | 41.14 M | 1.34% |
2017 | 40.6 M | 8.47% |
2016 | 37.43 M | 1.76% |
2015 | 36.78 M | 1.95% |
2014 | 36.07 M | 8.15% |
2013 | 33.36 M | 2.42% |
2012 | 32.57 M | 89.03% |
2011 | 17.23 M | 2904.39% |
2010 | 0.57 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Zogenix ZGNX | 55,340,700 | 19.23% | ๐บ๐ธ USA |
Recro Pharma
REPH | 23,565,700 | -49.23% | ๐บ๐ธ USA |
Omeros Corporation OMER | 62,856,721 | 35.42% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | 38,562,800 | -16.92% | ๐บ๐ธ USA |
Heron Therapeutics HRTX | 144,990,000 | 212.37% | ๐บ๐ธ USA |
Cara Therapeutics
CARA | 54,235,695 | 16.85% | ๐บ๐ธ USA |